Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Lung Cancer

Free Subscription 09.04.2008 2 Am J Clin Oncol 1 Ann Oncol 4 Anticancer Res 3 Cancer Res 2 Clin Cancer Res 2 Int J Cancer 6 Int J Radiat Oncol Biol Phys 1 J Clin Invest 3 J Clin Oncol 8 J Thorac Cardiovasc Surg 13 J Thorac Oncol 2 N Engl J Med 3 Oncogene

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Clin Oncol

1. GUABELLO G , Brunetti L, Palladini G, Musumeci S, et al
   Paraneoplastic Cushing's syndrome and nephrotic syndrome in a patient with disseminated small cell lung cancer.
   Am J Clin Oncol. 2008;31:102-3.
   PubMed     Related articles   
   
   
2. GOODGAME B , Viswanathan A, Miller CR, Gao F, et al
   A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer.
   Am J Clin Oncol. 2008;31:22-8.
   PubMed     Related articles    Abstract available
   
   

   
   Ann Oncol

3. GIACCONE G , Zucali PA
   Src as a potential therapeutic target in non-small-cell lung cancer.
   Ann Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   

   
   Anticancer Res

4. KOTTEAS E , Alamara C, Kiagia M, Pantazopoulos K, et al
   Safety and efficacy of zoledronic acid rapid infusion in lung cancer patients with bone metastases: a single institution experience.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
5. TISEO M , Ardizzoni A, Cafferata MA, Loprevite M, et al
   Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
6. MALUSECKA E , Krzyzowska-Gruca S, Gawrychowski J, Fiszer-Kierzkowska A, et al
   Stress proteins HSP27 and HSP70i predict survival in non-small cell lung carcinoma.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
7. HARDAVELLA G , Arkoumani E, Dalavanga Y, Galanis P, et al
   Prognostic impact of lymphangiogenesis and lymphatic invasion (CD105 expression) in small cell lung carcinoma.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   

   
   Cancer Res

8. HANN CL , Daniel VC, Sugar EA, Dobromilskaya I, et al
   Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer.
   Cancer Res. 2008;68:2321-8.
   PubMed     Related articles    Abstract available
   
   
9. VICENT S , Luis-Ravelo D, Anton I, Garcia-Tunon I, et al
   A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism.
   Cancer Res. 2008;68:2275-85.
   PubMed     Related articles    Abstract available
   
   
10. YATABE Y , Takahashi T, Mitsudomi T
    Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer.
    Cancer Res. 2008;68:2106-11.
    PubMed     Related articles    Abstract available
    
    

    
    Clin Cancer Res

11. FIDLER MJ , Argiris A, Patel JD, Johnson DH, et al
    The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib.
    Clin Cancer Res. 2008;14:2088-94.
    PubMed     Related articles    Abstract available
    
    
12. NA II , Byun BH, Kang HJ, Cheon GJ, et al
    18F-Fluoro-2-Deoxy-Glucose Uptake Predicts Clinical Outcome in Patients with Gefitinib-Treated Non-Small Cell Lung Cancer.
    Clin Cancer Res. 2008;14:2036-41.
    PubMed     Related articles    Abstract available
    
    

    
    Int J Cancer

13. HO MY , Sun GH, Leu SJ, Ka SM, et al
    Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
14. BARLESI F , Giaccone G, Gallegos-Ruiz MI, Span SW, et al
    Genotype analysis of the VNTR polymorphism in the SMYD3 histone methyltransferase gene: lack of correlation with the level of histone H3 methylation in NSCLC tissues or with the risk of NSCLC.
    Int J Cancer. 2008;122:1441-2.
    PubMed     Related articles   
    
    

    
    Int J Radiat Oncol Biol Phys

15. VIDETIC GM , Rice TW, Murthy S, Suh JH, et al
    Utility of Positron Emission Tomography Compared with Mediastinoscopy for Delineating Involved Lymph Nodes in Stage III Lung Cancer: Insights for Radiotherapy Planning from a Surgical Cohort.
    Int J Radiat Oncol Biol Phys. 2008;.
    PubMed     Related articles    Abstract available
    
    
16. PARK JK , Jung HY, Park SH, Kang SY, et al
    Combination of PTEN and gamma-Ionizing Radiation Enhances Cell Death and G(2)/M Arrest Through Regulation of AKT Activity and p21 Induction in Non-Small-Cell Lung Cancer Cells.
    Int J Radiat Oncol Biol Phys. 2008;70:1552-60.
    PubMed     Related articles    Abstract available
    
    
17. SURA S , Greco C, Gelblum D, Yorke ED, et al
    (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy.
    Int J Radiat Oncol Biol Phys. 2008;70:1397-402.
    PubMed     Related articles    Abstract available
    
    
18. PARK C , Papiez L, Zhang S, Story M, et al
    Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
    Int J Radiat Oncol Biol Phys. 2008;70:847-52.
    PubMed     Related articles    Abstract available
    
    
19. FAIRCHILD A , Goh P, Sinclair E, Barnes EA, et al
    Has the pattern of practice in the prescription of radiotherapy for the palliation of thoracic symptoms changed between 1999 and 2006 at the rapid response radiotherapy program?
    Int J Radiat Oncol Biol Phys. 2008;70:693-700.
    PubMed     Related articles    Abstract available
    
    
20. GUADAGNOLO BA , Zagars GK, Ballo MT, Patel SR, et al
    Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy.
    Int J Radiat Oncol Biol Phys. 2008;70:760-5.
    PubMed     Related articles    Abstract available
    
    

    
    J Clin Invest

21. BIANCHI F , Nuciforo P, Vecchi M, Bernard L, et al
    Survival prediction of stage I lung adenocarcinomas by expression of 10 genes.
    J Clin Invest. 2007;117:3436-44.
    PubMed     Related articles    Abstract available   Free Full Text
    
    

    
    J Clin Oncol

22. KELLY K , Chansky K, Gaspar LE, Albain KS, et al
    Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non-Small-Cell Lung Cancer: SWOG S0023.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
23. KEEDY VL , Arteaga CL, Johnson DH
    Does Gefitinib Shorten Lung Cancer Survival? Chaos Redux.
    J Clin Oncol. 2008;.
    PubMed     Related articles   
    
    
24. JEREMIC B , Koning C
    Induction chemotherapy before chemoradiation in locally advanced non-small-cell lung cancer: failure after failure, again and again.
    J Clin Oncol. 2008;26:e1-2.
    PubMed     Related articles   
    
    

    
    J Thorac Cardiovasc Surg

25. MARRA A , Hillejan L, Fechner S, Stamatis G, et al
    Remediastinoscopy in restaging of lung cancer after induction therapy.
    J Thorac Cardiovasc Surg. 2008;135:843-9.
    PubMed     Related articles    Abstract available
    
    
26. NOMORI H , Mori T, Ikeda K, Kawanaka K, et al
    Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
    J Thorac Cardiovasc Surg. 2008;135:816-22.
    PubMed     Related articles    Abstract available
    
    
27. NAGAOKA E , Yano M, Sugano T, Miyamoto T, et al
    Thrombus in the left superior pulmonary vein after left upper pulmonary lobectomy.
    J Thorac Cardiovasc Surg. 2008;135:709-10.
    PubMed     Related articles   
    
    
28. TASCI E , Orki A, Kutlu CA
    End-to-side bronchial anastomosis using the continuous suture technique.
    J Thorac Cardiovasc Surg. 2008;135:708-9.
    PubMed     Related articles   
    
    
29. SU JW , Mason DP, Murthy SC, Rice TW, et al
    Closure of a large tracheoesophageal fistula using AlloDerm.
    J Thorac Cardiovasc Surg. 2008;135:706-7.
    PubMed     Related articles   
    
    
30. JAROSZEWSKI DE , Huh J, Chu D, Malaisrie SC, et al
    Utility of detailed preoperative cardiac testing and incidence of post-thoracotomy myocardial infarction.
    J Thorac Cardiovasc Surg. 2008;135:648-55.
    PubMed     Related articles    Abstract available
    
    
31. NICASTRI DG , Wisnivesky JP, Litle VR, Yun J, et al
    Thoracoscopic lobectomy: report on safety, discharge independence, pain, and chemotherapy tolerance.
    J Thorac Cardiovasc Surg. 2008;135:642-7.
    PubMed     Related articles    Abstract available
    
    
32. REED CE , Graham A, Hoda RS, Khoor A, et al
    A simple two-gene prognostic model for adenocarcinoma of the lung.
    J Thorac Cardiovasc Surg. 2008;135:627-34.
    PubMed     Related articles    Abstract available
    
    

    
    J Thorac Oncol

33. LUDOVINI V , Gori S, Pistola L, Fazia MA, et al
    Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation.
    J Thorac Oncol. 2008;3:452-3.
    PubMed     Related articles   
    
    
34. DUDEK AZ , Chereddy S, Nguyen S, Wagner JE, et al
    Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.
    J Thorac Oncol. 2008;3:447-50.
    PubMed     Related articles    Abstract available
    
    
35. GRIDELLI C , Ardizzoni A, Ciardiello F, Hanna N, et al
    Second-line treatment of advanced non-small cell lung cancer.
    J Thorac Oncol. 2008;3:430-40.
    PubMed     Related articles    Abstract available
    
    
36. SCHULTZ EM , Silvestri GA, Gould MK
    Variation in experts' beliefs about lung cancer growth, progression, and prognosis.
    J Thorac Oncol. 2008;3:422-6.
    PubMed     Related articles    Abstract available
    
    
37. GOTO Y , Sekine I, Yamada K, Nokihara H, et al
    Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patients.
    J Thorac Oncol. 2008;3:412-6.
    PubMed     Related articles    Abstract available
    
    
38. CORTINOVIS D , Bidoli P, Cullura D, Lorusso V, et al
    Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?
    J Thorac Oncol. 2008;3:405-11.
    PubMed     Related articles    Abstract available
    
    
39. WONG AS , Soong R, Seah SB, Lim SW, et al
    Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer.
    J Thorac Oncol. 2008;3:400-4.
    PubMed     Related articles    Abstract available
    
    
40. DUDEK AZ , Larson T, McCleod MJ, Schneider DJ, et al
    Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer.
    J Thorac Oncol. 2008;3:394-9.
    PubMed     Related articles    Abstract available
    
    
41. KIURA K , Nakagawa K, Shinkai T, Eguchi K, et al
    A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer.
    J Thorac Oncol. 2008;3:386-93.
    PubMed     Related articles    Abstract available
    
    
42. AGARWALA A , Fisher W, Bruetman D, McClean J, et al
    Gefitinib plus celecoxib in chemotherapy-naive patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group.
    J Thorac Oncol. 2008;3:374-9.
    PubMed     Related articles    Abstract available
    
    
43. LUDOVINI V , Pistola L, Gregorc V, Floriani I, et al
    Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    J Thorac Oncol. 2008;3:365-73.
    PubMed     Related articles    Abstract available
    
    
44. MAROM EM , Martinez CH, Truong MT, Lei X, et al
    Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer.
    J Thorac Oncol. 2008;3:351-7.
    PubMed     Related articles    Abstract available
    
    
45. BEAU-FALLER M , Ruppert AM, Voegeli AC, Neuville A, et al
    MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naive cohort.
    J Thorac Oncol. 2008;3:331-9.
    PubMed     Related articles    Abstract available
    
    

    
    N Engl J Med

46. HENSCHKE C
    Clarification of Funding of Early Lung Cancer Study.
    N Engl J Med. 2008;.
    PubMed     Related articles       Free Full Text
    
    
47. BERGOT E , Paparel P, Zalcman G
    Sarcoidosis.
    N Engl J Med. 2008;358:1404.
    PubMed     Related articles   
    
    

    
    Oncogene

48. CHEN Z , Feng J, Saldivar JS, Gu D, et al
    EGFR somatic doublets in lung cancer are frequent and generally arise from a pair of driver mutations uncommonly seen as singlet mutations: one-third of doublets occur at five pairs of amino acids.
    Oncogene. 2008;.
    PubMed     Related articles    Abstract available
    
    
49. XIAO W , Zhang Q, Habermacher G, Yang X, et al
    U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
50. WENDT MK , Cooper AN, Dwinell MB
    Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.
    Oncogene. 2008;27:1461-71.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: